Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Structure-Function Relationships of the Follicle-Stimulating Hormone Receptor.

Ulloa-Aguirre A, Zariñán T, Jardón-Valadez E, Gutiérrez-Sagal R, Dias JA.

Front Endocrinol (Lausanne). 2018 Nov 29;9:707. doi: 10.3389/fendo.2018.00707. eCollection 2018. Review.

2.

Molecular dynamics simulation of the follicle-stimulating hormone receptor. Understanding the conformational dynamics of receptor variants at positions N680 and D408 from in silico analysis.

Jardón-Valadez E, Castillo-Guajardo D, Martínez-Luis I, Gutiérrez-Sagal R, Zariñán T, Ulloa-Aguirre A.

PLoS One. 2018 Nov 21;13(11):e0207526. doi: 10.1371/journal.pone.0207526. eCollection 2018.

3.

Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry.

García-Jiménez G, Zariñán T, Rodríguez-Valentín R, Mejía-Domínguez NR, Gutiérrez-Sagal R, Hernández-Montes G, Tovar A, Arechavaleta-Velasco F, Canto P, Granados J, Moreno-Macias H, Tusié-Luna T, Pellicer A, Ulloa-Aguirre A.

Reprod Biol Endocrinol. 2018 Oct 19;16(1):100. doi: 10.1186/s12958-018-0420-4.

4.

Thyroid hormones and breast cancer association according to menopausal status and body mass index.

Ortega-Olvera C, Ulloa-Aguirre A, Ángeles-Llerenas A, Mainero-Ratchelous FE, González-Acevedo CE, Hernández-Blanco ML, Ziv E, Avilés-Santa L, Pérez-Rodríguez E, Torres-Mejía G.

Breast Cancer Res. 2018 Aug 9;20(1):94. doi: 10.1186/s13058-018-1017-8.

5.

FSH Receptor Signaling: Complexity of Interactions and Signal Diversity.

Ulloa-Aguirre A, Reiter E, Crépieux P.

Endocrinology. 2018 Aug 1;159(8):3020-3035. doi: 10.1210/en.2018-00452. Review.

PMID:
29982321
6.

Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders.

Hou ZS, Ulloa-Aguirre A, Tao YX.

Expert Rev Clin Pharmacol. 2018 Jun;11(6):611-624. doi: 10.1080/17512433.2018.1480367. Epub 2018 Jun 11. Review.

PMID:
29851355
7.

Intracellular Trafficking of Gonadotropin Receptors in Health and Disease.

Ulloa-Aguirre A, Zariñán T, Gutiérrez-Sagal R, Dias JA.

Handb Exp Pharmacol. 2018;245:1-39. doi: 10.1007/164_2017_49. Review.

PMID:
29063275
8.

Preface.

Villarreal-Garza C, Castro-Sanchez A, Ulloa-Aguirre A.

Rev Invest Clin. 2017 Mar-Apr;69(2):57-58.

9.

The follicle-stimulating hormone receptor Asn680Ser polymorphism is associated with preterm birth in Hispanic women.

Dominguez-Lopez P, Diaz-Cueto L, Arechavaleta-Velasco M, Caldiño-Soto F, Ulloa-Aguirre A, Arechavaleta-Velasco F.

J Matern Fetal Neonatal Med. 2018 Mar;31(5):580-585. doi: 10.1080/14767058.2017.1292245. Epub 2017 Feb 28.

PMID:
28282771
10.

The Follitropin Receptor: Matching Structure and Function.

Ulloa-Aguirre A, Zariñán T.

Mol Pharmacol. 2016 Nov;90(5):596-608. Epub 2016 Jul 5. Review. Erratum in: Mol Pharmacol. 2017 Jan;91(1):48.

PMID:
27382014
11.

Clinical Applications of Gonadotropins in the Male.

Ulloa-Aguirre A, Lira-Albarrán S.

Prog Mol Biol Transl Sci. 2016;143:121-174. doi: 10.1016/bs.pmbts.2016.08.003. Epub 2016 Sep 13. Review.

PMID:
27697201
12.

Role of Cysteine Residues in the Carboxyl-Terminus of the Follicle-Stimulating Hormone Receptor in Intracellular Traffic and Postendocytic Processing.

Melo-Nava B, Casas-González P, Pérez-Solís MA, Castillo-Badillo J, Maravillas-Montero JL, Jardón-Valadez E, Zariñán T, Aguilar-Rojas A, Gallay N, Reiter E, Ulloa-Aguirre A.

Front Cell Dev Biol. 2016 Jul 20;4:76. doi: 10.3389/fcell.2016.00076. eCollection 2016.

13.

Preface.

Ulloa-Aguirre A.

Rev Invest Clin. 2016 Mar-Apr;68(2):52.

14.
15.

Pharmacoperones: targeting therapeutics toward diseases caused by protein misfolding.

Ulloa-Aguirre A, Zariñán T, Conn PM.

Rev Invest Clin. 2015 Jan-Feb;67(1):15-9.

16.

Editorial.

Kershenobich D, Ruiz-Palacios G, Ulloa-Aguirre A, Arrieta Ó, Selman M.

Rev Invest Clin. 2015 Jan-Feb;67(1):4.

17.

Single-molecule analyses of fully functional fluorescent protein-tagged follitropin receptor reveal homodimerization and specific heterodimerization with lutropin receptor.

Mazurkiewicz JE, Herrick-Davis K, Barroso M, Ulloa-Aguirre A, Lindau-Shepard B, Thomas RM, Dias JA.

Biol Reprod. 2015 Apr;92(4):100. doi: 10.1095/biolreprod.114.125781. Epub 2015 Mar 11.

18.

Constitutive activity in gonadotropin receptors.

Ulloa-Aguirre A, Reiter E, Bousfield G, Dias JA, Huhtaniemi I.

Adv Pharmacol. 2014;70:37-80. doi: 10.1016/B978-0-12-417197-8.00002-X. Review.

PMID:
24931192
19.

Estrogen-regulated transcription of the uteroglobin gene from the brown hare (Lepus capensis).

Acosta-Montesdeoca A, Zariñán T, Ulloa-Aguirre A, Gutiérrez-Sagal R.

Gen Comp Endocrinol. 2014 Apr 1;199:94-101. doi: 10.1016/j.ygcen.2014.01.006. Epub 2014 Jan 27.

PMID:
24480634
20.

Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens.

Conn PM, Smithson DC, Hodder PS, Stewart MD, Behringer RR, Smith E, Ulloa-Aguirre A, Janovick JA.

Pharmacol Res. 2014 May;83:38-51. doi: 10.1016/j.phrs.2013.12.004. Epub 2013 Dec 25. Review.

21.

"Pharmacoperone": what's in a word?

Conn PM, Ulloa-Aguirre A, Janovick JA.

Pharmacol Res. 2014 May;83:1-2. doi: 10.1016/j.phrs.2013.11.005. Epub 2013 Nov 20. Review. No abstract available.

PMID:
24269962
22.

Editorial for the MCE special issue on "Novel endocrine mechanisms in the regulation of reproduction".

Dias JA, Ulloa-Aguirre A, Bousfield GR, Reiter E.

Mol Cell Endocrinol. 2014 Jan 25;382(1):385-386. doi: 10.1016/j.mce.2013.10.005. Epub 2013 Oct 15. No abstract available.

PMID:
24139927
23.

Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle.

Palacios-González B, Zarain-Herzberg A, Flores-Galicia I, Noriega LG, Alemán-Escondrillas G, Zariñan T, Ulloa-Aguirre A, Torres N, Tovar AR.

Biochim Biophys Acta. 2014 Jan;1841(1):132-40. doi: 10.1016/j.bbalip.2013.08.018. Epub 2013 Sep 5.

PMID:
24013029
24.

Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Ulloa-Aguirre A, Zariñán T, Dias JA, Conn PM.

Mol Cell Endocrinol. 2014 Jan 25;382(1):411-423. doi: 10.1016/j.mce.2013.06.024. Epub 2013 Jun 24. Review.

25.

Trafficking of the follitropin receptor.

Ulloa-Aguirre A, Dias JA, Bousfield G, Huhtaniemi I, Reiter E.

Methods Enzymol. 2013;521:17-45. doi: 10.1016/B978-0-12-391862-8.00002-8.

26.

[Coverage for birth care in Mexico and its interpretation within the context of maternal mortality].

Lazcano-Ponce E, Schiavon R, Uribe-Zúñiga P, Walker D, Suárez-López L, Luna-Gordillo R, Ulloa-Aguirre A.

Salud Publica Mex. 2013;55 Suppl 2:S214-24. Spanish.

PMID:
24626698
27.

Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.

Aguilar-Rojas A, Huerta-Reyes M, Maya-Núñez G, Arechavaleta-Velásco F, Conn PM, Ulloa-Aguirre A, Valdés J.

BMC Cancer. 2012 Nov 23;12:550. doi: 10.1186/1471-2407-12-550.

28.

Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.

Maya-Núñez G, Ulloa-Aguirre A, Janovick JA, Conn PM.

Subcell Biochem. 2012;63:263-89. doi: 10.1007/978-94-007-4765-4_14. Review.

PMID:
23161143
29.

Differential effect of DDT, DDE, and DDD on COX-2 expression in the human trophoblast derived HTR-8/SVneo cells.

Dominguez-Lopez P, Diaz-Cueto L, Olivares A, Ulloa-Aguirre A, Arechavaleta-Velasco F.

J Biochem Mol Toxicol. 2012 Nov;26(11):454-60. doi: 10.1002/jbt.21444. Epub 2012 Nov 6.

PMID:
23132776
30.

Normal testicular function without detectable follicle-stimulating hormone. A novel mutation in the follicle-stimulating hormone receptor gene leading to apparent constitutive activity and impaired agonist-induced desensitization and internalization.

Casas-González P, Scaglia HE, Pérez-Solís MA, Durand G, Scaglia J, Zariñán T, Dias JA, Reiter E, Ulloa-Aguirre A.

Mol Cell Endocrinol. 2012 Nov 25;364(1-2):71-82. doi: 10.1016/j.mce.2012.08.011. Epub 2012 Aug 26.

PMID:
22954680
31.

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.

Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.

J Hypertens. 2012 Nov;30(11):2173-81. doi: 10.1097/HJH.0b013e328357c0c9.

PMID:
22902831
32.

Cloning the uteroglobin gene promoter from the relic volcano rabbit (Romerolagus diazi) reveals an ancient estrogen-response element.

Acosta-MontesdeOca A, Zariñán T, Macías H, Pérez-Solís MA, Ulloa-Aguirre A, Gutiérrez-Sagal R.

Mol Reprod Dev. 2012 May;79(5):337-45. doi: 10.1002/mrd.22030. Epub 2012 Mar 2.

PMID:
22389214
33.

[Health Law section in the Gaceta Médica de México].

Kershenobich Stalnikowitz D, Ulloa-Aguirre A, Larrea F.

Gac Med Mex. 2012 Jan-Feb;148(1):5. Spanish. No abstract available.

34.

Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Ulloa-Aguirre A, Michael Conn P.

Recent Pat Endocr Metab Immune Drug Discov. 2011 Jan;5(1):13-24. Review.

35.

Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.

Conn PM, Ulloa-Aguirre A.

Adv Pharmacol. 2011;62:109-41. doi: 10.1016/B978-0-12-385952-5.00008-7. Review.

36.

Novel pathways in gonadotropin receptor signaling and biased agonism.

Ulloa-Aguirre A, Crépieux P, Poupon A, Maurel MC, Reiter E.

Rev Endocr Metab Disord. 2011 Dec;12(4):259-74. doi: 10.1007/s11154-011-9176-2. Review.

PMID:
21526415
37.

The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization.

Thomas RM, Nechamen CA, Mazurkiewicz JE, Ulloa-Aguirre A, Dias JA.

Endocrinology. 2011 Apr;152(4):1691-701. doi: 10.1210/en.2010-1353. Epub 2011 Feb 1.

38.

Biochemical mechanism of pathogenesis of human gonadotropin-releasing hormone receptor mutants Thr104Ile and Tyr108Cys associated with familial hypogonadotropic hypogonadism.

Maya-Núñez G, Janovick JA, Aguilar-Rojas A, Jardón-Valadez E, Leaños-Miranda A, Zariñan T, Ulloa-Aguirre A, Conn PM.

Mol Cell Endocrinol. 2011 Apr 30;337(1-2):16-23. doi: 10.1016/j.mce.2011.01.016. Epub 2011 Jan 26.

39.

Preferential β-arrestin signalling at low receptor density revealed by functional characterization of the human FSH receptor A189 V mutation.

Tranchant T, Durand G, Gauthier C, Crépieux P, Ulloa-Aguirre A, Royère D, Reiter E.

Mol Cell Endocrinol. 2011 Jan 1;331(1):109-18. doi: 10.1016/j.mce.2010.08.016. Epub 2010 Aug 27.

PMID:
20801186
40.

Emerging roles for the FSH receptor adapter protein APPL1 and overlap of a putative 14-3-3τ interaction domain with a canonical G-protein interaction site.

Dias JA, Mahale SD, Nechamen CA, Davydenko O, Thomas RM, Ulloa-Aguirre A.

Mol Cell Endocrinol. 2010 Nov 25;329(1-2):17-25. doi: 10.1016/j.mce.2010.05.009. Epub 2010 Jun 19.

41.

Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys.

Zariñán T, Perez-Solís MA, Maya-Núñez G, Casas-González P, Conn PM, Dias JA, Ulloa-Aguirre A.

Mol Cell Endocrinol. 2010 Jun 10;321(2):112-22. doi: 10.1016/j.mce.2010.02.027. Epub 2010 Mar 4.

42.

Stimulating autoantibodies against the angiotensin II type 1 receptor are not associated with preeclampsia in Mexican-Mestizo women.

Leaños-Miranda A, Campos-Galicia I, Alvarez-Jiménez G, Isordia-Salas I, Rivera-Leaños R, Ulloa-Aguirre A.

J Hypertens. 2010 Apr;28(4):834-41. doi: 10.1097/HJH.0b013e3283376cc6.

PMID:
20139770
43.

Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Conn PM, Ulloa-Aguirre A.

Trends Endocrinol Metab. 2010 Mar;21(3):190-7. doi: 10.1016/j.tem.2009.11.003. Epub 2009 Dec 11. Review.

44.

Reproductive axis function and gonadotropin microheterogeneity in a male rat model of diet-induced obesity.

Olivares A, Méndez JP, Zambrano E, Cárdenas M, Tovar A, Perera-Marín G, Ulloa-Aguirre A.

Gen Comp Endocrinol. 2010 Apr 1;166(2):356-64. doi: 10.1016/j.ygcen.2009.12.007. Epub 2009 Dec 11.

PMID:
20005231
45.

Expression of progranulin (Acrogranin/PCDGF/Granulin-Epithelin Precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line.

Cuevas-Antonio R, Cancino C, Arechavaleta-Velasco F, Andrade A, Barron L, Estrada I, Fernandez RL, Olguin V, Ruiz S, Imani F, Zeferino-Toquero M, Ulloa-Aguirre A, Gerton GL, Diaz-Cueto L.

Cancer Invest. 2010 Jun;28(5):452-8. doi: 10.3109/07357900903346455.

PMID:
19863344
46.

Molecular cloning and functional analysis of the FSH receptor gene promoter from the volcano mouse (Neotomodon alstoni alstoni).

Pérez-Solis MA, Macías H, Acosta-MontesdeOca A, Pasapera AM, Fierro R, Ulloa-Aguirre A, Gutiérrez-Sagal R.

Endocrine. 2010 Feb;37(1):98-105. doi: 10.1007/s12020-009-9254-3. Epub 2009 Oct 28.

PMID:
19862645
47.

Pituitary-testicular axis function, biological to immunological ratio and charge isoform distribution of pituitary LH in male rats with experimental diabetes.

Olivares A, Méndez JP, Cárdenas M, Oviedo N, Palomino MA, Santos I, Perera-Marín G, Gutiérrez-Sagal R, Ulloa-Aguirre A.

Gen Comp Endocrinol. 2009 May;161(3):304-12. doi: 10.1016/j.ygcen.2008.12.021. Epub 2009 Jan 31.

PMID:
19523385
48.

Hormonal regulation of pituitary FSH sialylation in male rats.

Ambao V, Rulli SB, Carino MH, Cónsole G, Ulloa-Aguirre A, Calandra RS, Campo S.

Mol Cell Endocrinol. 2009 Oct 15;309(1-2):39-47. doi: 10.1016/j.mce.2009.05.002. Epub 2009 May 21.

PMID:
19464343
49.

Targeting of G protein-coupled receptors to the plasma membrane in health and disease.

Ulloa-Aguirre A, Conn PM.

Front Biosci (Landmark Ed). 2009 Jan 1;14:973-94. Review.

PMID:
19273112
50.

Conformational effects of Lys191 in the human GnRH receptor: mutagenesis and molecular dynamics simulations studies.

Jardón-Valadez E, Aguilar-Rojas A, Maya-Núñez G, Leaños-Miranda A, Piñeiro A, Conn PM, Ulloa-Aguirre A.

J Endocrinol. 2009 May;201(2):297-307. doi: 10.1677/JOE-08-0527. Epub 2009 Feb 26.

Supplemental Content

Loading ...
Support Center